2009, Number 1-3
<< Back Next >>
Cir Plast 2009; 19 (1-3)
Upper-limb allotransplant development at The National Institute of Medical Sciences and Nutrition Salvador Zubiran
Iglesias MM, Butrón P, Santander FSA, Ricaño EDIM, Negrete NJP, Pérez MMF, González CAM, González CMA, de Rienzo MB
Language: Spanish
References: 29
Page: 85-92
PDF size: 329.93 Kb.
ABSTRACT
The Subcommittee of Composite Tissue Transplant of the National Institute of Medical Sciences and Nutrition Salvador Zubirán was formed in 2005. Its mission was to evaluate medical, surgical, legal, social and ethical issues involved in upper limb allotransplant,according to the criteria established by «The International Registry of Hand and Composite Tissue Transplantation» and the Mexican General Health Law and Regulation concerning tissue and organ donation and transplantation. Additionally a surgical training and upper limb harvesting programs were designed. The outcome was the creation of an upper limb transplantation protocol, an information letter, and the informed consent letter. These documents were approved by the Institute Ethics Committee in 2007, and in 2006 a sanitary license was granted by the Federal Commission for Sanitary Risks Protection, which enables the Institute to carry out the allotransplant. The protocol was registered in the National Transplant Center in February 2007, and was updated in March 2009, at the time the first candidate patient was registered, too. And so the Institute is now waiting for a donor.
REFERENCES
Brouha PCR , Ildstad ST. Mixed allogenic chimeris: Past, presentand prospects for the future. Transplantation 2001; 72: S32-S42.
Edgell SE, McCabe SJ, Breidenbach WC et al. Different reference frames can lead to different hand transplantation decisions by patients and physicians. J Hand Surg [Am] 2001; 26: 196-200.
Vossen M, Brouha PCR . Composite tissue allotransplantation. Functional, immunological and ethical aspects. Thesis. University of Uthrecht. The Netherlands 2007: pp. 9-17.
Siemionow M, Agaoglu G. Tissue transplantation in plastic surgery. Clin Plast Surg 2007; 34: 251-69.
T obin GR, Bridenbach WC, Ildstad ST, Marvin MM, Buell JF, Ravindra KV. The history of human composite tissue allotransplantation. Transplant Proc 2009; 41(2): 466-471.
International Registry on Hand and Composite Tissue Transplantation. IRHCT Web site. Available at: http://www.handregistry. com
Lanzetta M, Petruzzo P, Dubernard JM, Margreiter R, Schuind F, Breidenbach WD et al. Second report (1998-2006) of the International registry of Hand and Composite Tissue Transplantation. Transplant Immunology 2007; 18: 1-6.
Lanzetta M, Petruzzo P. A comprehensive functional store system. In Hand transplantation. Lanzetta M, Dubernard JM. Verlag, Italia: Springer 2007: pp. 355-362.
T obin G, Breidenbach W, Pidwell D, IldstadS, Ravindra K. Transplantation of the hand, face and composite structure: Evolution and current status. Clin Plast Surg 2007; 34: 271-278.
Perez-Abadia G, Lauretin-Pérez, Gorantla VS et al. Low-dose immunosuppression in a rathind-limb transplantation model. Transplant International 2003; 16: 835-842.
Bonati H, Brandacher G, Margreiter R, Schneeberger. Infectious complications in three double hand recipients. Experience from a single center. Transplantation Proceedings 2009; 41: 517-520.
Kaufman DB, Shapiro R, Lucey MR et al. Immunosuppression: Practice and trends. Am J Transplant 2004; 4 (9):38-53.
Sayegh MH, Carpenter CB. Transplantation 50 years later: Progress, challenges, and promises. N Engl J Med 2004; 23: 351; 26:2761-2766.
Instituto Mexicano del Seguro Social: Estadísticas sobre accidentes de trabajo por tipo de lesión y sexo. División técnica de información estadística en salud. http://www.imss.gob.mx
Lanzetta M. Hand transplantation as an evolution of microsurgery: A logical step towards better reconstructive options. In: Hand transplantation: Lanzetta M, Dubernard JM (Editors) Verlag, Italia: Springer 2007: pp. 11-23.
Petruzzo P, Lanzetta M, Dubernard JM et al. The international registry on hand and composite tissue transplantation. Transplantation 2008; 86(4): 487-492.
Linda C, Breidenbach W. Hand transplantation. Hand Clin 2001; 17: 499-510.
D ubernard JM, Petruzzo P et al. Functional results of the first human double-hand transplantation. Ann Surg 2003; 238: 128-136.
Landin L, Cavadas PC, Ibáñez J, Roger I, Sempere FV. CD 3+_ Mediated rejection and C4d deposition in two composite tissue (Bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 2009; 87(5): 776-781.
Lee WP, Yaremchuk MJ, Pan YC et al. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87(3): 401-411.
Hale G. The CD 52 antigen and development of the CAMPATH antibodies. Cytotherapy 2001; 3(3): 137-143.
Levi DM, Tzakis AG, Kato T et al. Transplantation of the abdominal wall. Lancet 2003; 361(9376): 2173-2176.
Schneeberger S, Gorantla VS, van Riet RP et al. Atypical acute rejection after hand transplantation. Am J Transplant 2008; 8(3): 688-696.
Jacquet ET, Schanie CL, Fugler-Vivier I et al. Facilitating cells as a venue to establish mixed chimerism and tolerance. Pediatr Transplant 2003; 7(5): 348-357.
R avindra KV, Wu S, Bozulic L et al: Composite tissue transplantation: a rapidly advancing field. Transplant Proc 2008; 40(5): 1237-1248.
Sacks JM, Kuo YR, Tajeb A, Breitinger J, Nguyen VT, Thomson AW, Feili-Hariri M, Lee WP. Prolongation of composite tissue allograft survival by immature recipient dendritic cells pulsed with donor antigen and transient low-dose immunosuppression. Plast Reconstr Surg 2008; 121: 37-49.
Siemionow MZ, Izycki DM, Zielinski M. Donor specific tolerancein fully major histocompatibility complex-mismatched limb allograft transplants under an anti-alpha beta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation 2003; 76(12): 1662-1668.
Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Ann Rev Immunol 2003; 21: 685-711.
D ubernard JM, Owen ER, Herzberg G et al. Human hand allograft: report on first 6 months. Lancet 1999; 353: 1315-1320.